SIRPant Immunotherapeutics Overview
- Founded
- 2020

- Status
- Private
- Employees
- 4

- Latest Deal Type
- Early Stage VC
- Latest Deal Amount
- $1.5M

- Investors
- 1
SIRPant Immunotherapeutics General Information
Description
Developer of cancer-specific immunotherapy intended to focus on the development of novel autologous cell therapy for solid tumors. The company's technology employs an Adoptive Cell Therapy (ACT) approach to elicit tumor-specific T-cells resulting in a polyclonal immune response against multiple tumor antigens, helping doctors to treat solid tumors efficiently.
Contact Information
- 1590 Bunker Court
- Chambersburg, PA 17202-8040
- United States
SIRPant Immunotherapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Early Stage VC | 30-Nov-2020 | $1.5M | 00.00 | Completed | Startup |
SIRPant Immunotherapeutics Comparisons
Industry
0000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSIRPant Immunotherapeutics Competitors (10)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Carisma Therapeutics | Venture Capital-Backed | Philadelphia, PA | 00 | 00000 | 00000000000 | 00000 |
0000000000 000000 | Venture Capital-Backed | Windsor, United Kingdom | 0000 | 0000000000 0 | 0000 | |
000 00000000 | Formerly VC-backed | Burlingame, CA | 00 | 00000 | 00000000 | 00000 |
0000 00000000 | Venture Capital-Backed | Brisbane, CA | 00 | 000.00 | 000000000 - | 000.00 |
0000000 0000000000 | Venture Capital-Backed | Bedford, MA | 000.00 | 0000000000 0 | 000.00 |
SIRPant Immunotherapeutics Executive Team (3)
SIRPant Immunotherapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSIRPant Immunotherapeutics Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
BioAdvance | Venture Capital | Minority | 000 0000 | 000000 0 |